Potential mechanisms underlying increased b-catenin in CML cells include BCR-ABLmediated b-catenin phosphorylation [37] and GSK3β inactivation [38], leading to protein stabilization of β-catenin. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.